-
Články
- Časopisy
- Kurzy
- Témy
- Kongresy
- Videa
- Podcasty
Medical Device Regulation: Time to Improve Performance
article has not abstract
Vyšlo v časopise: Medical Device Regulation: Time to Improve Performance. PLoS Med 9(7): e32767. doi:10.1371/journal.pmed.1001277
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001277Souhrn
article has not abstract
Zdroje
1. MeierB (2009) Medtronic links device for heart to 13 deaths. The New York Times. March 13, 2009. Available: http://www.nytimes.com/2009/03/14/business/14device.html. Accessed 11 May 2012.
2. HauserRG, AlmquistAK (2008) Learning from our mistakes? Testing new ICD technology. N Engl J Med 359 : 2517–2519.
3. KramerDB, XuS, KesselheimAS (2012) How does medical device regulation perform in the US and EU? A systematic review. PLoS Med 9: e1001276 doi:10.1371/journal.pmed.1001276.
4. ZuckermanDM, BrownP, NissenSE (2011) Medical device recalls and the FDA approval process. Arch Intern Med 171 : 1006–1011.
5. HallRF (April 13, 2011) Delicate balance: FDA and the reform of the medical device approval process. Written testimony for U.S. Senate Committee on Aging. Available: http://aging.senate.gov/events/hr233hr.pdf. Accessed 22 April 2012.
6. U.S. House of Representatives Committee on Energy and Commerce (2011) Medical journal editors raise significant concerns with validity of industry-funded reports. July 21, 2011. Available: http://democrats.energycommerce.house.gov/index.php?q=news/medical-journal-editors-raise-significant-concerns-with-validity-of-industry-funded-reports. Accessed 1 May 2012.
7. MakowerJ (2011) Impact of medical device regulation on jobs and patients. Written testimony for the U.S. House of Representatives Committee on Energy and Commerce. February 17, 2011. Available: http://energycommerce.house.gov/hearings/hearingdetail.aspx?NewsID=8221. Accessed 29 June 2012.
8. OkieS (2010) Reviving the FDA. N Engl J Med 363 : 1492–1494.
9. MakowerJ, MeerA, DenendL (2010) FDA impact on U.S. medical technology innovation: a survey of over 200 medical technology companies. November 2010
10. HinesJZ, LurieP, YuE, WolfeS (2010) Left to their own devices: breakdowns in United States medical device premarket review. PLoS Med 7: e1000280 doi:10.1371/journal.pmed.1000280.
11. BurgessM (2011) Comments in “Impact of Medical Device Regulation on Jobs and Patients.”. House of Representatives, Subcommittee on Health, Committee on Energy and Commerce. February 17, 2011.
12. FraserAG, DaubertJ-C, Van De WerfF, EstesM, SmithSC, et al. (2011) Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology. Eur Heart J 32 : 1673–1686.
13. ThompsonM, HeneghanC, BillingsleyM, CohenD (2011) Medical device recalls and transparency in the UK. BMJ 342: d2973.
14. O'ConnorAB (2009) The need for improved access to FDA reviews. JAMA 302 : 191–193.
Štítky
Interné lekárstvo
Článek Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-AnalysisČlánek The Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing WorldČlánek Researching New Methods of Screening for Adverse Pregnancy Outcome: Lessons from Pre-eclampsiaČlánek HIV Treatment as Prevention: Models, Data, and Questions—Towards Evidence-Based Decision-MakingČlánek United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study
Článok vyšiel v časopisePLOS Medicine
Najčítanejšie tento týždeň
2012 Číslo 7- Statinová intolerance
- Projekt MedPed
- Index SAMS-CI pro odhad souvislosti myopatií s léčbou statiny
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Hydroresponzivní krytí v epitelizační fázi hojení rány
-
Všetky články tohto čísla
- HIV Treatment as Prevention: Issues in Economic Evaluation
- Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
- HIV Treatment as Prevention: Natural Experiments Highlight Limits of Antiretroviral Treatment as HIV Prevention
- HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes
- Reduction in Infection Rates after Mandatory Hospital Public Reporting: Findings from a Longitudinal Cohort Study in Canada
- Medical Device Regulation: Time to Improve Performance
- Averting an Impending Storm: Can We Reengineer Health Systems to Meet the Needs of Aging Populations?
- Thinking Forward: The Quicksand of Appeasing the Food Industry
- The Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing World
- Community Mobilization in Mumbai Slums to Improve Perinatal Care and Outcomes: A Cluster Randomized Controlled Trial
- Researching New Methods of Screening for Adverse Pregnancy Outcome: Lessons from Pre-eclampsia
- Social Entrepreneurship for Sexual Health (SESH): A New Approach for Enabling Delivery of Sexual Health Services among Most-at-Risk Populations
- Lessons from Agriculture for the Sustainable Management of Malaria Vectors
- HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions
- HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention
- Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
- The Effectiveness of Emergency Obstetric Referral Interventions in Developing Country Settings: A Systematic Review
- Digital Humanitarianism: Collective Intelligence Emerging
- The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?
- “Big Food,” the Consumer Food Environment, Health, and the Policy Response in South Africa
- Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective Study
- HIV Treatment as Prevention: The Utility and Limitations of Ecological Observation
- How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review
- HIV Treatment as Prevention: Models, Data, and Questions—Towards Evidence-Based Decision-Making
- Risk Factors for Death among Children Less than 5 Years Old Hospitalized with Diarrhea in Rural Western Kenya, 2005–2007: A Cohort Study
- United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study
- HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?
- HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling for Public Health Decision-Making in All Modes of Prevention and Evaluation
- Effect of a Community-Based Nursing Intervention on Mortality in Chronically Ill Older Adults: A Randomized Controlled Trial
- Surveillance of Infection Severity: A Registry Study of Laboratory Diagnosed
- Consequences of Gestational Diabetes in an Urban Hospital in Viet Nam: A Prospective Cohort Study
- Integrating Mental Health and Development: A Case Study of the BasicNeeds Model in Nepal
- Treatment of Young Children with HIV Infection: Using Evidence to Inform Policymakers
- The Impact of Transnational “Big Food” Companies on the South: A View from Brazil
- HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
- PLOS Medicine
- Archív čísel
- Aktuálne číslo
- Informácie o časopise
Najčítanejšie v tomto čísle- HIV Treatment as Prevention: Issues in Economic Evaluation
- HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions
- HIV Treatment as Prevention: The Utility and Limitations of Ecological Observation
- Consequences of Gestational Diabetes in an Urban Hospital in Viet Nam: A Prospective Cohort Study
Prihlásenie#ADS_BOTTOM_SCRIPTS#Zabudnuté hesloZadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
- Časopisy